PharVision Advisers’s Pilgrim's Pride PPC Stock Holding History

PharVision Advisers’s Portfolio PPC Stock Details PPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,351	Closed	-$259K	–	938
2025 Q3	$259K	Buy	+6,351	New	+$288K	0.15%	311

Other funds holding PPC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

PharVision Advisers's PPC Position: Q4 2025 in Review

PharVision Advisers sold out of Pilgrim's Pride (PPC) in Q4 2025, closing a stake of 6,351 shares — an estimated $259K sold.

PharVision Advisers first reported a position in PPC in Q3 2025 and held it in 1 quarter. The position peaked at $259K in Q3 2025. 374 funds tracked by Wall St. Rank hold PPC as of Q4 2025.

PharVision Advisers reported no remaining Pilgrim's Pride position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 6,351 Pilgrim's Pride shares in Q4 2025, an estimated $259K.
PharVision Advisers first reported a position in Pilgrim's Pride in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Pilgrim's Pride position peaked at $259K in Q3 2025.
374 funds tracked by Wall St. Rank held Pilgrim's Pride as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.